SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-022938
Filing Date
2019-11-14
Accepted
2019-11-14 16:45:57
Documents
47
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cbli20190930_10q.htm 10-Q 815404
2 EXHIBIT 31.1 ex_160545.htm EX-31.1 12614
3 EXHIBIT 32.1 ex_160546.htm EX-32.1 7124
  Complete submission text file 0001437749-19-022938.txt   3728365

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cbli-20190930.xml EX-101.INS 794193
5 XBRL TAXONOMY EXTENSION SCHEMA cbli-20190930.xsd EX-101.SCH 35753
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbli-20190930_cal.xml EX-101.CAL 29076
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbli-20190930_def.xml EX-101.DEF 235223
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbli-20190930_lab.xml EX-101.LAB 233827
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbli-20190930_pre.xml EX-101.PRE 257785
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32954 | Film No.: 191221178
SIC: 8731 Services-Commercial Physical & Biological Research